ReviewFrontiers in oncology2021
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.
Jerry L Spivak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewFrontiers in oncology2021
Jerry L Spivak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.